MENA Leaders Advocate Holistic Housing Policy at Baku Forum Beyond Construction to Livelihoods and Climate Tax Foundation OpEd Challenges Claims That Tariffs Strengthen US Economy BP Removes Chair Albert Manifold Over Governance and Conduct Concerns Bessent Predicts Substantial Disinflation as Warsh Assumes Fed Leadership RBC Capital Resumes Coverage on Danaher Corporation DHR What Investors Should Know Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Aiming for Higher Returns by 2028 RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance Citi Q1 2026 Earnings EPS Surpasses Estimates by 133 Amid Improved Operational Efficiency GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick SYK Q1 2026 Earnings EPS Misses Expectations as Stock Edges Lower GPOR Q1 2026 Earnings EPS Slightly Misses Consensus Shares Edge Lower Universal Technical Institute Inc UTI Q1 2026 Earnings EPS Misses Estimates Amid Mixed Signals Stock Surges Ambiq Micro AMBQ Shows Resilience with 186 Gain as Stock Holds Above Key Support Daxor Corporation DXR Holds Steady at 1082 as Shares Test Key Support Zone Aurora Cannabis ACB Slips 28 as Shares Test Key Support Zone CCNEP Preferred Shares Edge Higher Amid Steady Trading Support and Resistance in Focus Bluerock Acquisition Corp Unit BLRKU Holds Steady at 1002 Amid Quiet Trading Disneys The Mandalorian and Grogu Opens to 82 Million Marking a Low Point for Star Wars Franchise GENI Q1 2026 Earnings Significant EPS Miss Despite Stock Rally Freightos Limited CRGO Edges Lower as Stock Tests Key Support Near 194 Transdigm Group TDG Holds Steady Near Key Support Levels Amid Modest Gains Medalist Diversified Inc MDRR Declines Sharply Testing Key Support Levels Perpetua Resources PPTA Surges 5 Key Levels and Drivers Behind the Move Smurfit WestRock SW Shows Modest Uptick as Stock Holds Above Support Valley National Bancorp Preferred Stock VLYPO Holds Steady Near 2512 Key Support and Resistance in Focus AFGC Edges Higher Subordinated Debenture Shows Resilience at 1842 NRX Pharmaceuticals NRXP Surges 523 on Renewed Buying Interest Near Support